Printer Friendly

ELAN AND WARNER LAMBERT UNIT FORM JOINT VENTURE MARKETING COMPANY IN U.K.

 ELAN AND WARNER LAMBERT UNIT FORM JOINT VENTURE
 MARKETING COMPANY IN U.K.
 ATHLONE, Ireland, July 16 /PRNewswire/ -- Elan Corporation PLC (AMEX: ELN) said today it reached agreement with Parke Davis UK (a unit of Warner Lambert (NYSE: WLA)) to form a joint venture to market a range of Elan-developed products in the U.K.
 The joint venture, to be called Elan Pharma Ltd., builds on the successful marketing collaboration between Elan and Parke Davis in Ireland.
 Donald E. Panoz, Elan's chairman and chief executive officer, said "We're delighted to further develop our relationship with Warner Lambert, this development is part of our mind to market strategy and provides a cost effective way for us to establish a profitable foothold in the $7 billion U.K. pharmaceutical market."
 Elan Corporation is a leader in the specialized health care field of advanced reformulation and drug delivery, concentrating on improved drug absorption and utilization. It operates research and manufacturing facilities in Athlone, Ireland; Gainesville, Ga.; Enschede, Netherlands; Manila, Philippines; Brea, Calif.; Cambridge, Mass.; and Mezzovico, Switzerland.
 -0- 7/16/92
 /CONTACT: Brian Crotty of Elan, 800-252-3526; or Thomas Redington, 203-222-7399 or 212-926-1733, for Elan/
 (ELN WLA) CO: Elan Corporation plc; Warner Lambert ST: New York IN: MTC SU:


SH-TS -- NY006 -- 9856 07/16/92 08:35 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 16, 1992
Words:215
Previous Article:AT&T REPORTS RECORD NET INCOME FOR QUARTER
Next Article:ADVANCED VISUAL SYSTEMS, INTEL ANNOUNCE PLANS TO MAKE AVS AVAILABLE ON INTEL SUPERCOMPUTERS
Topics:


Related Articles
WARNER-LAMBERT, RHONE-POULENC RORER AGREE TO CO-DEVELOP AND CO-PROMOTE ADVANCED QUINOLONE ANTIBACTERIAL IN U.S. AND CANADA
WARNER-LAMBERT ANNOUNCES GLOBAL PARTNERSHIP WITH WELLCOME P.L.C.
WARNER-LAMBERT, WELLCOME AND GLAXO ANNOUNCE STRATEGIC ALLIANCES
WARNER-LAMBERT AND GLAXO ANNOUNCE Rx-TO-OTC JOINT VENTURE
GLAXO AND WARNER-LAMBERT ANNOUNCE OTC JOINT VENTURE
WARNER-LAMBERT; WELLCOME ENTER OTC JOINT VENTURE
ELAN ANNOUNCES NEW JOINT VENTURE IN SPAIN
Warner-Lambert, Sankyo Announce Joint Venture Partnership and Co-Promotion Agreement
Emisphere and Elan Finalize Joint Venture Agreement
Elan Announces Steps to Consolidate and Build Its U.K. and Irish Pharmaceutical Businesses

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters